Jung Sin-Ho
Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
Contemp Clin Trials Commun. 2017 Sep;7:23-27. doi: 10.1016/j.conctc.2017.04.008. Epub 2017 May 5.
With the development of inexpensive treatment regimens and less invasive surgical procedures, we are confronted with non-inferiority study objectives. A non-inferiority phase III trial requires a roughly four times larger sample size than that of a similar standard superiority trial. Because of the large required sample size, we often face feasibility issues to open a non-inferiority trial. Furthermore, due to lack of phase II non-inferiority trial design methods, we do not have an opportunity to investigate the efficacy of the experimental therapy through a phase II trial. As a result, we often fail to open a non-inferiority phase III trial and a large number of non-inferiority clinical questions still remain unanswered. In this paper, we want to develop some designs for non-inferiority randomized phase II trials with feasible sample sizes. At first, we review a design method for non-inferiority phase III trials. Subsequently, we propose three different designs for non-inferiority phase II trials that can be used under different settings. Each method is demonstrated with examples. Each of the proposed design methods is shown to require a reasonable sample size for non-inferiority phase II trials. The three different non-inferiority phase II trial designs are used under different settings, but require similar sample sizes that are typical for phase II trials.
随着廉价治疗方案和侵入性较小的外科手术的发展,我们面临着非劣效性研究目标。一项非劣效性III期试验所需的样本量大约是类似标准优效性试验的四倍。由于所需样本量较大,我们在开展非劣效性试验时经常面临可行性问题。此外,由于缺乏II期非劣效性试验设计方法,我们没有机会通过II期试验来研究实验性疗法的疗效。因此,我们常常无法开展非劣效性III期试验,大量非劣效性临床问题仍未得到解答。在本文中,我们希望开发一些具有可行样本量的非劣效性随机II期试验设计。首先,我们回顾一种非劣效性III期试验的设计方法。随后,我们提出三种不同的非劣效性II期试验设计,可在不同情况下使用。每种方法都通过实例进行了说明。所提出的每种设计方法都表明,对于非劣效性II期试验需要合理的样本量。这三种不同的非劣效性II期试验设计在不同情况下使用,但所需样本量与II期试验的典型样本量相似。